135 related articles for article (PubMed ID: 25693669)
1. Prognostic value of tumor shrinkage versus fragmentation following radiochemotherapy and surgery for rectal cancer.
Hav M; Libbrecht L; Geboes K; Ferdinande L; Boterberg T; Ceelen W; Pattyn P; Cuvelier C
Virchows Arch; 2015 May; 466(5):517-23. PubMed ID: 25693669
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
[TBL] [Abstract][Full Text] [Related]
3. Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?
Reggiani Bonetti L; Lionti S; Domati F; Barresi V
World J Gastroenterol; 2017 Feb; 23(8):1412-1423. PubMed ID: 28293088
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
5. Combination of growth pattern and tumor regression identifies a high-risk group in neoadjuvant treated rectal cancer patients.
Jessberger J; Erlenbach-Wünsch K; Posselt R; Haderlein M; Agaimy A; Fietkau R; Hartmann A; Distel L
J Dig Dis; 2017 May; 18(5):283-291. PubMed ID: 28342240
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: the French randomised trial ACCORD12/0405 PRODIGE 2.
Rullier A; Gourgou-Bourgade S; Jarlier M; Bibeau F; Chassagne-Clément C; Hennequin C; Tisseau L; Leroux A; Ettore F; Peoc'h M; Diebold MA; Robin YM; Kleinclaus I; Mineur L; Petitjean C; Mosnier JF; Soubeyran I; Padilla N; Lemaistre AI; Bérille J; Denis B; Conroy T; Gérard JP
Eur J Cancer; 2013 Jan; 49(1):82-9. PubMed ID: 22909998
[TBL] [Abstract][Full Text] [Related]
7. Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.
Sprenger T; Conradi LC; Beissbarth T; Ermert H; Homayounfar K; Middel P; Rüschoff J; Wolff HA; Schüler P; Ghadimi BM; Rödel C; Becker H; Rödel F; Liersch T
Cancer; 2013 Jan; 119(1):26-35. PubMed ID: 22736392
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma.
Fernández-Aceñero MJ; Granja M; Sastre J; García-Paredes B; Estrada L
Virchows Arch; 2016 Apr; 468(4):425-30. PubMed ID: 26754675
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
McCoy MJ; Hemmings C; Hillery S; Penter C; Bulsara MK; Zeps N; Platell CF
ANZ J Surg; 2017 Dec; 87(12):E233-E239. PubMed ID: 26631340
[TBL] [Abstract][Full Text] [Related]
10. [Downstaging correlates the prognosis of rectal cancer after intensified neoadjuvant chemoradiotherapy].
Xiao Y; Lu J; Zhong G; Xiong G; Wu B; Lin G; Xue H; Qiu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):547-50. PubMed ID: 24953359
[TBL] [Abstract][Full Text] [Related]
11. Pathological prognostic factors in locally advanced rectal carcinoma after neoadjuvant radiochemotherapy: analysis of 113 cases.
Sannier A; Lefèvre JH; Panis Y; Cazals-Hatem D; Bedossa P; Guedj N
Histopathology; 2014 Nov; 65(5):623-30. PubMed ID: 24701980
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.
Sun Y; Zhang Y; Wu X; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X; Chi P
J Surg Oncol; 2018 Mar; 117(4):737-744. PubMed ID: 29228455
[TBL] [Abstract][Full Text] [Related]
13. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
14. The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Cui J; Yang L; Guo L; Shao Y; Tan D; Li N; Zhang H
Oncotarget; 2017 Jun; 8(23):37845-37854. PubMed ID: 28103579
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of circumferential resection margin involvement in patients with locally-advanced rectal cancer].
Alecha JS; Ribera EB; Dorronsoro M; Ripa CZ; Cabezón JH; Tricas JM
Cir Esp; 2007 Jan; 81(1):18-22. PubMed ID: 17263953
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of rectal carcinoma after multimodal treatment: ypTNM classification and tumor regression grading are essential.
Hermanek P; Merkel S; Hohenberger W
Anticancer Res; 2013 Feb; 33(2):559-66. PubMed ID: 23393349
[TBL] [Abstract][Full Text] [Related]
17. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status.
Kulkarni T; Gollins S; Maw A; Hobson P; Byrne R; Widdowson D
Colorectal Dis; 2008 Jun; 10(5):479-89. PubMed ID: 18318754
[TBL] [Abstract][Full Text] [Related]
19. Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series.
Sastre J; Serrano JJ; Fernández C; Ramirez C; Ortega L; García-Paredes B; Corona J; Alfonso R; Córdoba S; Díaz-Rubio E
Clin Colorectal Cancer; 2016 Jun; 15(2):128-34. PubMed ID: 26385572
[TBL] [Abstract][Full Text] [Related]
20. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
Mawdsley S; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Osborne M; Livingstone JI; MacDonald P; Mitchell IC; Meyrick-Thomas J; Northover JM; Windsor A; Novell R; Wallace M
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):745-52. PubMed ID: 16199310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
